DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,895,601 | +1.8% | 23,763 | -1.5% | 3.44% | +6.2% |
| Q2 2023 | $5,792,400 | -3.8% | 24,135 | +1.0% | 3.24% | -11.3% |
| Q1 2023 | $6,023,504 | -4.5% | 23,899 | +0.6% | 3.65% | -7.7% |
| Q4 2022 | $6,305,052 | -1.4% | 23,755 | -4.1% | 3.95% | -10.6% |
| Q3 2022 | $6,395,000 | +1.6% | 24,760 | -0.3% | 4.42% | +15.4% |
| Q2 2022 | $6,295,000 | -13.4% | 24,833 | +0.2% | 3.83% | -5.5% |
| Q1 2022 | $7,272,000 | -15.3% | 24,792 | -5.0% | 4.05% | -2.1% |
| Q4 2021 | $8,590,000 | +7.1% | 26,108 | -0.9% | 4.14% | -1.0% |
| Q3 2021 | $8,022,000 | +5.3% | 26,351 | -7.2% | 4.18% | -1.0% |
| Q2 2021 | $7,618,000 | +19.8% | 28,388 | +0.5% | 4.22% | +10.2% |
| Q1 2021 | $6,359,000 | -77.4% | 28,253 | +352.4% | 3.84% | +37.9% |
| Q4 2020 | $28,112,000 | +359.0% | 6,245 | -78.0% | 2.78% | -32.7% |
| Q3 2020 | $6,125,000 | +10.8% | 28,443 | -9.0% | 4.13% | +2.2% |
| Q2 2020 | $5,526,000 | +24.3% | 31,250 | -2.7% | 4.04% | +2.4% |
| Q1 2020 | $4,446,000 | -19.3% | 32,125 | -10.5% | 3.95% | +4.6% |
| Q4 2019 | $5,509,000 | +4.4% | 35,896 | -1.7% | 3.77% | -2.6% |
| Q3 2019 | $5,276,000 | +1.0% | 36,528 | -0.1% | 3.87% | +5.0% |
| Q2 2019 | $5,224,000 | +4.6% | 36,552 | -3.4% | 3.69% | +0.5% |
| Q1 2019 | $4,996,000 | +30.6% | 37,841 | +2.0% | 3.67% | +10.5% |
| Q4 2018 | $3,824,000 | -6.4% | 37,081 | -1.4% | 3.32% | +11.8% |
| Q3 2018 | $4,087,000 | -99.9% | 37,612 | +1.0% | 2.97% | -12.6% |
| Q2 2018 | $3,674,251,000 | +102906.8% | 37,234 | +2.2% | 3.40% | +17.4% |
| Q1 2018 | $3,567,000 | +4.1% | 36,435 | -1.4% | 2.90% | +5.8% |
| Q4 2017 | $3,428,000 | -0.5% | 36,935 | -1.1% | 2.74% | -14.1% |
| Q3 2017 | $3,445,000 | +11.5% | 37,336 | +1.9% | 3.19% | +19.7% |
| Q2 2017 | $3,091,000 | +1.3% | 36,625 | -0.1% | 2.66% | +0.7% |
| Q1 2017 | $3,051,000 | +11.7% | 36,649 | +4.4% | 2.64% | -20.4% |
| Q4 2016 | $2,731,000 | +0.4% | 35,088 | +1.1% | 3.32% | -5.0% |
| Q3 2016 | $2,719,000 | -20.7% | 34,697 | +2.2% | 3.50% | -20.9% |
| Q2 2016 | $3,430,000 | +4.8% | 33,965 | -1.6% | 4.42% | +6.1% |
| Q1 2016 | $3,274,000 | +2.2% | 34,514 | +0.1% | 4.16% | -1.6% |
| Q4 2015 | $3,203,000 | -1.7% | 34,490 | +0.7% | 4.23% | -0.4% |
| Q3 2015 | $3,259,000 | +10.4% | 34,262 | -0.7% | 4.25% | +7.0% |
| Q2 2015 | $2,953,000 | +0.2% | 34,503 | -0.6% | 3.97% | +4.8% |
| Q1 2015 | $2,947,000 | -4.3% | 34,719 | -3.4% | 3.79% | -0.9% |
| Q4 2014 | $3,080,000 | +12.7% | 35,946 | -0.1% | 3.83% | -0.3% |
| Q3 2014 | $2,733,000 | +13.2% | 35,982 | +17.3% | 3.84% | -4.7% |
| Q2 2014 | $2,415,000 | +4.0% | 30,679 | -1.0% | 4.03% | -3.7% |
| Q1 2014 | $2,323,000 | -4.9% | 30,977 | -2.1% | 4.19% | -6.6% |
| Q4 2013 | $2,443,000 | +9.9% | 31,646 | -1.3% | 4.48% | +7.8% |
| Q3 2013 | $2,223,000 | +6.8% | 32,066 | -2.4% | 4.16% | -1.4% |
| Q2 2013 | $2,081,000 | – | 32,871 | – | 4.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |